Pages that link to "Q34775354"

The following pages link to Extracorporeal photochemotherapy for the treatment of graft-versus-host disease (Q34775354):

Displaying 42 items.

• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24187102) (← links)
• Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24187108) (← links)
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24200272) (← links)
• Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24200282) (← links)
• Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24200648) (← links)
• Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients (Q24202963) (← links)
• Clinical applications of therapeutic apheresis (Q30451700) (← links)
• The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society (Q33628638) (← links)
• Guidelines on the use of extracorporeal photopheresis (Q34918643) (← links)
• Mechanisms of action of extracorporeal photochemotherapy (Q35183850) (← links)
• Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cells (Q35209490) (← links)
• Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. (Q36036186) (← links)
• Clinical Results of Extracorporeal Photopheresis (Q36210320) (← links)
• Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis (Q36225775) (← links)
• Chronic graft versus host disease of oral mucosa: review of available therapies (Q36382986) (← links)
• Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression? (Q36498959) (← links)
• Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations (Q36721438) (← links)
• Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells (Q36835217) (← links)
• Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease (Q37453628) (← links)
• Extracorporeal photopheresis: from solid organs to face transplantation (Q37467220) (← links)
• Pathophysiology of GvHD and Other HSCT-Related Major Complications (Q37710572) (← links)
• Extra corporeal photo chemotherapy (ECP) in acute and chronic GVHD (Q37798348) (← links)
• The role of the extracorporeal photopheresis in the management of the graft-versus-host disease (Q37962159) (← links)
• Extracorporeal photopheresis in acute and chronic graft-versus-host disease (Q38208102) (← links)
• Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature (Q38216786) (← links)
• Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data (Q38642534) (← links)
• Extracorporeal photopheresis: Review of technical aspects (Q41953441) (← links)
• Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease (Q43273885) (← links)
• PUVA apoptotic response in activated and resting human lymphocytes (Q44348971) (← links)
• Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System (Q46072379) (← links)
• Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. (Q46460065) (← links)
• Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy (Q46693351) (← links)
• Technical report: effects of PUVA treatment on the optical properties of blood/tissue storage bags during extracorporeal photochemotherapy (Q46930693) (← links)
• National survey of apheresis activity in Italy (2000). (Q47238393) (← links)
• What is the role of apheresis technology in stem cell transplantation? (Q49835983) (← links)
• Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. (Q53859811) (← links)
• First-line extracorporeal photochemotherapy for acute GVHD after unmanipulated haploidentical BMT following nonmyeloablative conditioning and post transplantation CY. (Q54628564) (← links)
• Monocytes show immunoregulatory capacity on CD4 T-cells in a human in vitro model of extracorporeal photopheresis (Q58578166) (← links)
• Extracorporeal photochemotherapy: a historical perspective (Q73086625) (← links)
• Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody (Q73833684) (← links)
• Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease (Q75331787) (← links)
• [A case of chronic graft vs host disease treated with photopheresis] (Q80886950) (← links)